National Human Trafficking Hotline: 1-888-373-7888 | Text 233733
Organ trafficking, the recruitment, transport, or receipt of persons for the purpose of organ removal, represents one of the most extreme forms of human trafficking. Driven by a global gap between organ demand and supply, criminal networks exploit the desperate on both sides: patients who will die without transplants, and impoverished or coerced individuals whose organs are taken through force, fraud, or exploitation. The World Health Organization estimates that up to 10% of organ transplants worldwide involve trafficked organs.
Scale of Organ Trafficking
Organ trafficking is inherently difficult to quantify due to its clandestine nature and the involvement of medical professionals who have both the skills and institutional cover to conceal the practice. The Declaration of Istanbul Custodian Group, the leading international body on ethical transplantation, identifies three primary forms of organ trafficking:
- Trafficking in persons for organ removal (TPOR): Recruiting or transporting individuals specifically for the purpose of removing their organs through force, coercion, or deception
- Organ trafficking: The illicit procurement, transport, or implantation of organs outside of legitimate transplant systems
- Transplant tourism: Patients traveling abroad to purchase organs from trafficked or exploited donors
The Lancet published a 2024 analysis identifying organ trafficking hotspots in China, India, Pakistan, Egypt, Iran, and parts of Central America. The study noted that organ trafficking frequently intersects with other forms of exploitation: victims may be migrants subjected to debt bondage, prisoners of conscience, or impoverished individuals who are deceived about the risks and compensation of organ “donation.”
China’s Forced Organ Harvesting
The most extensively documented state-sponsored organ trafficking program in the modern era involves the People’s Republic of China. Multiple independent investigations have concluded that China has systematically harvested organs from prisoners of conscience, primarily Falun Gong practitioners, and that this practice has expanded to include Uyghur Muslims and other detained minorities.
The China Tribunal
In June 2019, the independent China Tribunal, chaired by Sir Geoffrey Nice KC (former lead prosecutor at the International Criminal Tribunal for the former Yugoslavia), delivered its final judgment after a year-long investigation. The Tribunal concluded unanimously and beyond reasonable doubt that:
1. Forced organ harvesting has been committed for years on a substantial scale in China
2. Falun Gong practitioners have been one, and probably the main, source of organs for forced harvesting
3. The Tribunal had no evidence that the practice has stopped
4. The scale of organ transplantation in China cannot be explained by voluntary donors alone
5. The short wait times advertised by Chinese hospitals (days to weeks, compared to years in other countries) are consistent with organs being sourced on demand from a living prisoner population
Falun Gong Practitioners
Falun Gong, a spiritual practice combining meditation with moral teachings, was banned by the Chinese government in 1999. The subsequent persecution resulted in the detention of hundreds of thousands of practitioners. Former Canadian Secretary of State David Kilgour and human rights lawyer David Matas published a series of investigations (2006, 2007, and updated in 2016) concluding that 60,000–100,000 transplants per year were being performed in China; far exceeding the number that could be accounted for by voluntary donors or executed death-row prisoners.
Their methodology analyzed hospital capacity, bed utilization rates, transplant infrastructure expansion, and publicly available revenue data from Chinese transplant hospitals. They documented cases of Chinese hospitals advertising organ wait times of one to two weeks; a timeframe that is medically impossible under a voluntary donation system, where the average wait in the US is three to five years for a kidney.
Uyghur Muslims
Since 2017, reports have emerged that Uyghur detainees in Xinjiang internment camps are being subjected to systematic blood testing and medical examinations consistent with organ compatibility screening; a practice not explained by routine healthcare. The China Tribunal noted evidence suggesting that the targeting of Uyghurs for forced organ harvesting was expanding, though Falun Gong practitioners remained the primary documented victim group.
China officially reformed its organ transplant system in 2015, announcing that it would rely exclusively on voluntary citizen donations. However, independent analyses of Chinese transplant data by BMC Medical Ethics (2019) and others have identified statistical anomalies, including data that appeared to be algorithmically generated rather than reflecting genuine donation patterns, raising doubts about the veracity of China’s claimed reforms.
Transplant Tourism
Transplant tourism occurs when patients travel internationally to obtain organs that are sourced through trafficking or exploitation. The practice is driven by organ shortages in wealthy countries and enabled by medical infrastructure in destination countries that operates outside ethical oversight.
Middle East
Patients from Gulf states, Israel, and other Middle Eastern countries have historically traveled to China, India, Pakistan, and the Philippines for transplants. Israel was among the first countries to address this directly: after investigative journalism by Israeli media documented patients traveling to China for transplants likely sourced from executed prisoners, Israel passed the Organ Transplant Act of 2008, which prohibits organ brokering and restricts insurance coverage for transplants obtained abroad without ethical certification.
South Asia
India and Pakistan have been major destinations for transplant tourism. In India, the kidney bazaars of Tamil Nadu and other regions operated semi-openly for decades, with impoverished villagers selling kidneys for $1,000–$5,000 while recipients paid $50,000–$150,000, with intermediaries capturing the difference. India’s Transplantation of Human Organs Act (1994, amended 2011) prohibits organ sales but enforcement remains inconsistent, particularly in rural areas.
In Pakistan, an estimated 2,000 kidneys were being transplanted annually from living paid “donors” before the Transplantation of Human Organs and Tissues Ordinance of 2007. A significant number of donors were bonded laborers, migrants, or individuals in debt bondage who were coerced by their employers or creditors into selling a kidney.
Kosovo Organ Trafficking Case
The Kosovo organ trafficking case represents one of the few instances where organ trafficking was investigated and prosecuted by an international legal body. In 2008, former Chief Prosecutor of the International Criminal Tribunal for the former Yugoslavia Carla Del Ponte published allegations that organs were harvested from Serbian prisoners by the Kosovo Liberation Army (KLA) during the 1999 Kosovo War.
A Council of Europe investigation led by Dick Marty confirmed in 2010 that a small number of Serbian and Albanian prisoners were transported to Albania where their organs were removed and sold to international recipients. The investigation implicated senior KLA figures, including individuals who subsequently held high political office. The EU-backed Specialist Prosecutor’s Office in The Hague has pursued related cases, though prosecutions have been complicated by witness intimidation and the passage of time.
In 2013, five individuals were convicted in a separate but related case (EULEX prosecution) involving an Israeli-led organ trafficking ring operating a clinic in Pristina, Kosovo, that performed at least 30 illegal kidney transplants using vulnerable donors from Turkey, Moldova, Russia, and Kazakhstan.
Black Market Networks
Black market organ networks typically involve a chain of actors: recruiters who identify vulnerable individuals, brokers who connect donors with recipients, surgeons willing to perform the operations, and hospitals or clinics that provide surgical facilities. The Global Financial Integrity organization estimates the illegal organ trade generates $840 million to $1.7 billion annually.
Broker Networks
Organ brokers operate as intermediaries, often posing as legitimate medical tourism facilitators. They recruit “donors” from impoverished communities with promises of compensation, typically $5,000–$10,000 for a kidney, while charging recipients $100,000–$200,000. In many documented cases, donors receive less than promised or nothing at all. Post-operative care for donors is minimal or absent, leading to long-term health complications and disability.
Online Organ Markets
The internet has created new channels for organ trafficking. Researchers have documented organ solicitation on social media platforms, classified advertisement sites, and messaging apps. A 2019 study published in the American Journal of Transplantation identified organ sale advertisements across multiple platforms, predominantly offering kidneys, with posts originating from India, Pakistan, Bangladesh, and several African countries.
The Organ Shortage Crisis
Organ trafficking exists because legitimate organ supply falls dramatically short of demand. Understanding the shortage is essential to understanding the trafficking it generates.
In the United States, over 103,000 people are on the organ transplant waiting list. Approximately 17 people die each day waiting for a transplant. The gap between supply and demand has widened despite increases in both deceased and living donation. Globally, the WHO estimates that only about 10% of the global need for organ transplants is met through legitimate channels.
Opt-out donation (presumed consent): Adopted by Spain, Wales, France, and others; citizens are default donors unless they register to opt out. Spain achieves the world’s highest donation rate (49.6 per million population)
Paired kidney exchange: Algorithmically matches incompatible donor-recipient pairs across chains
Xenotransplantation: Genetically modified pig organs transplanted into humans (first procedures performed 2022–2024)
Regulated compensation: Iran’s legal kidney market (the only country that permits organ sales) has eliminated its kidney waiting list, though critics identify coercion risks
International Legal Response
Declaration of Istanbul
The Declaration of Istanbul on Organ Trafficking and Transplant Tourism (2008, updated 2018) is the primary international ethical framework governing organ transplantation. Endorsed by over 135 countries and professional organizations, it establishes principles including:
- Governments should develop and implement comprehensive legal frameworks to prohibit organ trafficking
- Organ allocation should be based on medical criteria, not financial or commercial considerations
- Transplant tourism that relies on trafficked organs should be prohibited
- Living organ donors should be protected by informed consent, medical evaluation, and long-term follow-up
- National self-sufficiency in organ donation should be pursued to reduce dependence on international organ trade
Council of Europe Convention
The Council of Europe Convention against Trafficking in Human Organs (2015) is the first binding international treaty specifically addressing organ trafficking. It criminalizes the removal of organs from living or deceased donors without valid consent or in exchange for financial gain, as well as the solicitation and recruitment of donors or recipients, the preparation and preservation of illicitly removed organs, and the implantation of organs known to have been illicitly obtained. As of 2024, the Convention has been signed by 25 countries and ratified by 13.
United States
The National Organ Transplant Act of 1984 (NOTA) prohibits the sale of human organs in the United States, with violations carrying penalties of up to five years imprisonment and $50,000 in fines. The Trafficking Victims Protection Act (TVPA) applies to cases where organ trafficking involves human trafficking elements. However, prosecutions of organ trafficking in the United States remain extremely rare; the legal framework is primarily targeted at domestic organ sales rather than international organ trafficking networks.